The potential impact of GLS and PDHA1 on tumor immunity and immunotherapy response in LUSC [PDF]
Frontiers in GeneticsBackgroundLung squamous cell carcinoma (LUSC), a therapeutically challenging non-small cell lung cancer (NSCLC) subtype with a poor prognosis, exhibits heterogeneous responses to immunotherapy.
Wu Jiahui
exaly +4 more sources
Modulation of copper homeostasis and cuproptosis by PDHA1 in acute myeloid leukemia [PDF]
Discover OncologyBackground Acute myeloid leukemia (AML) is an aggressive malignancy with poor prognosis. Recent studies highlight cuproptosis, a copper-dependent cell death mechanism, as a potential therapeutic target in cancers.
Liu Haipeng
exaly +3 more sources
Astragaloside IV increases PDHA1 in mesenchymal stem cell exosomes to treat myocardial infarction [PDF]
Scientific ReportsAcute myocardial infarction (AMI) is a threat to health, with high morbidity and mortality, posing a challenge to the public health system. This study aimed to explore the efficacy and potential targets of Astragaloside IV (AS-IV) combined with ...
Chen Zhijie
exaly +3 more sources
Frontiers in Pharmacology, 2022 Recent studies have proposed that pyruvate dehydrogenase E1 component subunit alpha (PDHA1), a cuproptosis-key gene, is crucial to the glucose metabolism reprogram of tumor cells.
Langmei Deng +2 more
exaly +3 more sources
Cuproptosis-associated PDHA1 promotes sarcoma progression and immunotherapy responsiveness via the E2F1–PD-L1 axis: a multi-omics and clinical validation study [PDF]
npj Precision OncologySarcomas are aggressive, immunologically cold tumors with limited benefit from immune-checkpoint blockade (ICB). Through integrated multi-omics, functional, and clinical analyses, we identify pyruvate dehydrogenase alpha 1 (PDHA1)—a cuproptosis-linked ...
Haotian Qin +10 more
doaj +2 more sources
Frontiers in Neuroscience, 2021 Background and Purpose: Neurodegenerative diseases are associated with metabolic disturbances. Pyruvate dehydrogenase E1 component subunit alpha (PDHA1) is an essential component in the process of glucose metabolism, and its deficiency exists in various ...
, Tingting Bi, Bi Tingting
exaly +3 more sources
SIRT3 regulates PDHA1 acetylation in HUVECs to modulate inflammation and pyroptosis under clinorotation [PDF]
iScienceSummary: Microgravity-induced endothelial inflammation contributes to cardiovascular dysfunction in astronauts, but the metabolic mechanisms involved are not fully defined. Sirtuin-3 (SIRT3), a mitochondrial deacetylase, regulates cellular metabolism and
Min Jiang +9 more
doaj +2 more sources
Mitochondrial PDHA1 acetylation orchestrates lactate-dependent epigenetic reprogramming to promote fibrosis via NUAK2 [PDF]
Cellular and Molecular Life SciencesIdiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease with few effective treatment options. While metabolic reprogramming has been associated with IPF, the precise mechanisms connecting mitochondrial metabolic dysfunction to ...
Yujie Wang +11 more
doaj +2 more sources
PDHA1 enhances resistance to ferroptosis in anoikis-resistant prostate cancer by upregulating AIFM2 [PDF]
Cell Death DiscoveryCells that detach from the extracellular matrix (ECM) undergo various forms of cell death, including ferroptosis. Previous studies have demonstrated that prostate cancer (PCa) cells undergo ferroptosis following ECM detachment, and resistance to ...
Yukun Cong +10 more
doaj +2 more sources
PDHA1–acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancer [PDF]
Cell Death and DiseaseAcquired resistance to enzalutamide (Enz) presents a significant challenge in castration-resistant prostate cancer (CRPC), and overcoming this resistance remains an unmet clinical need.
Ruilin Zhuang +12 more
doaj +2 more sources